Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Coding Corner Question

From the College  |  Issue: September 2010  |  September 1, 2010

A 68-year-old established male patient with osteoarthritis of the lumbar region returns to the office for a scheduled paravertebral facet joint injection. The patient is currently on a nonsteroidal antiinflammatory drug, ranitidine, and glucosamine-chondroitin. He reports pain and stiffness in his lower lumbar area and denies any other complaints. The two facets at L4–L5 are each injected with glucocorticoid preparations. Fluoroscopic guidance is done for the supervision of needle placement.

How would this be coded?

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Click Here for the Answer.

Share: 

Filed under:Billing/CodingPractice Support Tagged with:BillingCodingInjectionOsteoarthritis

Related Articles

    Coding and Billing for Facet Joint Injections

    March 1, 2010

    Billing and coding is not as easy as one might think. The rules are constantly changing—and the codes for facet joint injections, which have changed frequently over the years, are a prime example. To make sure your practice is in compliance, billers, coders, and physicians should remain informed of the correct coding guidelines for facet joint injections. No one in a physician’s practice should ever assume that, because they coded a procedure a certain way in years past, it is still the status quo. Every rheumatologist and his or her staff should understand the what, why, and where of facet joint injections.

    Meet the Lumbar Spinal Stenosis Challenge

    August 1, 2007

    Limited evidence and diagnostic options make this increasing condition difficult to treat

    Your Coders Are as Good as Their Coding Tools

    September 1, 2010

    Are your coders equipped with the latest coding information? Every year there are changes to the diagnoses and procedure codes, whether this is deletion or newly created codes. Along with coding updates, insurance carriers frequently adjust, delete, or create medical policies to reflect updates to procedures or diagnose codes.

    The Complexity of Lumbar Spinal Stenosis

    June 10, 2012

    Challenges in diagnosis and management.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences